Celebrity endorsements by Elon Musk and Serena Williams have pushed weight loss medication into the mainstream. Demand is so ...

Trump announced popular weight loss treatments would be offered directly on a new “TrumpRx.gov” website at lower prices.

New research suggests GLP-1 weight-loss drugs like Ozempic and Zepbound may reduce cravings for alcohol and drugs by ...

Novo Nordisk (NVO) is cutting prices to challenge rival Eli Lilly (LLY) in the obesity-drug market, signaling a more ...

The Danish company is trying to regain market share from Eli Lilly — which makes Mounjaro and Zepbound — by making its weight ...

Novo also has started a temporary offer of $199 a month for the first two months of low doses of Wegovy and the drug’s ...

The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy ...

Novo Nordisk A/S is undercutting archrival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to ...

Novo Nordisk moved to cut U.S. prices on its leading GLP-1 weight-loss and diabetes drugs as competitive pressure from Eli ...

The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster medications.

Novo revealed Monday that the self-pay cost for the two lowest dosages of Wegovy and Ozempic will be $349 per month, down ...

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...